Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to
improve peopleís lives. The combined strengths of pharmaceuticals and diagnostics under one roof
have made Roche the leader in personalised healthcare _ a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the worldís largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat
diseases and make a sustainable contribution to society. The company also aims for improving
patient access to medical innovations by working with all relevant stakeholders. Twenty-nine
medicines developed by Roche are included in the World Health Organization Model Lists of
Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.
Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals,
Biotechnology; Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016
employed more than 94,000 people worldwide. In 2016, Roche invested CHF 9.9 billion in R&D
and posted sales of CHF 50.6 billion. Genentech, in the United States, is a wholly owned member
of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
For more information: http://www.roche.com or http://roche.jobs.
- Company Name:Roche
(View Trends)
-
Headquarters: (View Map)Basel, Basel-Stadt (de)
-
Hospital & Health Care
-
10,001+ employees
- 42340 Global Rank
- 29281 United States
- 1.32 M Estimated Visits
-
Search45.14%
-
Direct36.30%
-
Referrals11.33%
-
Mail4.45%
-
Social2.63%
-
Display0.15%
-
26.81%
-
13.84%
-
12.18%
-
5.12%
-
4.21%



-
Germany 34.3%
-
United States 24.2%
-
India 15.0%
-
Switzerland 4.2%
-
Canada 1.4%
- Biotechnology and Pharmaceuticals
- Pharmaceuticals
Ads
Cdns
Web Server
Javascript






Ns

Widgets

Framework
Analytics
Server

Hosting
Mx


Mobile
Media
Mapping
Cms
Cdn
Language

Ssl

Feeds
Cdn

Link

Payment

- 10 SDKs
- 3.0 Avg. Rating
- 3 Total reviews

- App Url: https://itunes.apple.com/app/roche-inc-/id1080812556
- App Support: http://www.coaguchekpatientservices.com/
- Genre: Medical
- Bundle ID: com.roche.CoaguChek
- App Size: 3.67 M
- Version: 1.0
- Release Date: March 21st, 2016
- Update Date: March 21st, 2016
Description:
The CoaguChek XS mPOC App is an accessory to Roche CoaguChek coagulation single-user systems. It transfers data from these devices to the CoaguChek Link IT solution, a Patient Self Testing (PST) and Health Care Professional (HCP) portal for coagulation monitoring.
mPOC kit requires Bluetooth LE, available on iPhone 4S or later or iPad 3 or later.
Do you want to learn more about the CoaguChek XS mPOC App system and CoaguChek Patient Services? Please call us at 1-800-779-7616
If you already have the CoaguChek XS mPOC App system and you require technical assistance, please call us 1-800-428-4674. We are unable to reply to App Store comments.





Sort by
finger pricker
charitmnacho
Good, but app could be better
Hillbilly swifts
Did not come with reader










-
Native3.89%
-
Standard90.56%
-
Direct5.56%




























Results please!